“AN IN-SILICO STUDY OF ANDALIMAN (Zanthoxylum Acanthopodium DC.) AS AN ANTICANCER AGENT AGAINST TYROSINE KINASE ENZYME INHIBITION USING THE DOCKING METHOD: IN SILICO MOLECULAR DOCKING STUDY OF ACTIVE COMPOUNDS FROM ANDALIMAN (Zanthoxylum Acanthopodium DC.) AGAINST TYROSINE KINASE ENZYME AS AN ANTICANCER AGENT”. 2026. Forte Journal 6 (1): 348-72. https://doi.org/10.51771/fj.v6i1.2155.